|Expense ratio (net)||N/A|
|Last cap gain||N/A|
|Morningstar risk rating||N/A|
|Beta (5Y monthly)||N/A|
|5y average return||N/A|
|Average for category||N/A|
When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses...
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
BARCELONA, Spain, Oct. 17, 2019 /PRNewswire/ -- Grifols (GRF.MC) (GRF.P.MC) (GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, today announced that it has obtained the CE mark for the Procleix Panther System featuring ART.